Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC has seen some interesting run up the past few days.

<< Previous

Bullboard Posts

Next >>

Comment by Hand2Handon Apr 07, 2021 7:59pm

268 Views

Post# 32954433

RE:RE:RE:RE:RE:RE:ONC has seen some interesting run up the past few days.

Kw - Sell shares on Friday? Eh, what? And miss the opprotunity of a life time? No thanks. I wouldn't even think of trying to time a "buyout/partnership" at this critical juncture of the companies history. I'm holding tight even if it means holding through a dollor or 2 pullback. It's impossible to predict when it will happen - it could be tomorrow or in a month or 2 - but it's going to happen. It's just crazy that we aren't even higher at this stage.

<< Previous

Bullboard Posts

Next >>

Transportation technology stock secures second major contract in a week